Schedule 13D Amendment No. 2

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13D/A

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(a) AND

AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

 

 

Saratoga Investment Corp.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

80349A 109

(CUSIP Number)

Christian L. Oberbeck

535 Madison Avenue

New York, New York 10022

(212) 750-3343

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

October 9, 2014

(Date of Event Which Requires Filing of this Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ¨

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


SCHEDULE 13D/A

 

CUSIP No. 80349A 109  

 

  1   

Name of Reporting Persons

I.R.S. Identification Nos. of Above Persons (Entities Only)

 

CHRISTIAN L. OBERBECK

  2  

Check the Appropriate Box if a Member of a Group

(a)  ¨        (b)  x

 

  3  

SEC Use Only

 

  4  

Source of Funds

 

PF

  5  

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ¨

 

  6  

Citizenship or Place of Organization

 

United States of America

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

     7    

Sole Voting Power

 

473,373

     8   

Shared Voting Power

 

1,098,956

     9   

Sole Dispositive Power

 

473,373

   10   

Shared Dispositive Power

 

1,098,956

11  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,572,329 (See Item 5 below)

12  

Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares  ¨

 

13  

Percent of Class Represented by Amount in Row (11)

 

29.2% (See Item 5)

14  

Type of Reporting Person

 

IN

 


CUSIP No. 80349A 109  

 

  1   

Name of Reporting Persons

I.R.S. Identification Nos. of Above Persons (Entities Only)

 

SARATOGA INVESTMENTS ADVISORS, LLC

(I.R.S. Identification No. 27-2235250)

  2  

Check the Appropriate Box if a Member of a Group

(a)  ¨        (b)  x

 

  3  

SEC Use Only

 

  4  

Source of Funds

 

WC

  5  

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ¨

 

  6  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

     7    

Sole Voting Power

 

0

     8   

Shared Voting Power

 

180,738

     9   

Sole Dispositive Power

 

0

   10   

Shared Dispositive Power

 

180,738

11  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

180,738 (See Item 5 below)

12  

Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares  ¨

 

13  

Percent of Class Represented by Amount in Row (11)

 

3.4% (See Item 5 below)

14  

Type of Reporting Person

 

IA

 


CUSIP No. 80349A 109  

 

  1   

Name of Reporting Persons

I.R.S. Identification Nos. of Above Persons (Entities Only)

 

CLO PARTNERS LLC

(I.R.S. Identification No. 20-5190132)

  2  

Check the Appropriate Box if a Member of a Group

(a)  ¨        (b)  x

 

  3  

SEC Use Only

 

  4  

Source of Funds

 

WC

  5  

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ¨

 

  6  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

     7    

Sole Voting Power

 

0

     8   

Shared Voting Power

 

174,035

     9   

Sole Dispositive Power

 

0

   10   

Shared Dispositive Power

 

174,035

11  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

174,035 (See Item 5 below)

12  

Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares  ¨

 

13  

Percent of Class Represented by Amount in Row (11)

 

3.2% (See Item 5 below)

14  

Type of Reporting Person

 

OO

 


This Amendment No. 2 amends and supplements the Schedule 13D originally filed jointly by Christian L. Oberbeck, Richard A. Petrocelli, Charles G. Phillips IV, John F. MacMurray, Charles P. Durkin, Jr., John P. Birkelund, Saratoga Investment Advisors, LLC and CLO Partners LLC on August 3, 2010 and Amendment No. 1 thereto filed by Christian L. Oberbeck on April 17, 2012 (collectively, the “Schedule 13D”). Except as expressly set forth herein, there have been no changes in the information set forth in the Schedule 13D.

Item 1. Security and Issuer

Item 1 is hereby amended and restated in its entirety as follows:

This Amendment No. 2 to the Schedule 13D is being filed jointly by Christian L. Oberbeck, Saratoga Investment Advisors, LLC and CLO Partners LLC to report the beneficial ownership of shares of the common stock, par value $0.001 per share (the “Common Stock”), of Saratoga Investment Corp., a Maryland corporation (the “Issuer”). Each of the foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons.” The principal executive office of the Issuer is located at 535 Madison Avenue, New York, NY 10022.

Item 2. Identity and Background

Item 2 is hereby amended and restated in its entirety:

This Schedule 13D is being filed jointly by the following persons:

 

  (1) Christian L. Oberbeck, a United States citizen, is the Chief Executive Officer and a member of the Board of Directors of the Issuer. Mr. Oberbeck is also the Managing Member of Saratoga Investment Advisors, LLC, the external investment adviser to the Issuer, and the Managing Partner of Saratoga Partners, an independent, New York-based merchant banking firm. The principal business and office address for Mr. Oberbeck is 535 Madison Avenue, New York, NY 10022.

 

  (2) Saratoga Investment Advisors, LLC, a Delaware limited liability company, is registered with the SEC as an investment advisor under the Investment Advisers Act of 1940, serves as the external investment adviser to the Issuer and is controlled by Mr. Oberbeck. The principal business and office address for Saratoga Investment Advisors, LLC is 535 Madison Avenue, 4th Floor, New York, NY 10022.

 

  (3) CLO Partners LLC, a Delaware limited liability company, is wholly owned by Mr. Oberbeck. The principal business and office address for CLO Partners LLC is 630 Lake Avenue, Greenwich, CT 06830.

During the last five years, none of the Reporting Persons has been (a) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (b) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which proceeding such Reporting Person is or was subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Item 4 Purpose of the Transaction

Item 4 is amended to add the following:

In connection with a domestic relations order, Mr. Oberbeck entered into an Agreement Relating to Shares of Common Stock of Saratoga Investment Corp. (the “Transfer Agreement”) with Elizabeth Oberbeck and agreed to transfer 744,183 shares of Common Stock beneficially owned by him to her pursuant to the terms thereof.


Except as set forth above or such as would occur upon completion of any of the actions discussed above, the Reporting Persons do not have any intention to engage in any of the transactions described in paragraphs (a) – (j) of Item 4 of Schedule 13D. The Reporting Persons reserve the right to determine in the future whether to change the purpose or purposes described above or whether to adopt plans or proposals of the type described in paragraphs (a) – (j) of Item 4 of Schedule 13D.

Item 5. Interest in Securities of the Issuer

Item 5 is hereby amended and restated in its entirety as follows:

(a) The percentages set forth below and otherwise herein are based on 5,379,616 shares of Common Stock outstanding as disclosed in the Issuer’s Quarterly Report on Form 10-Q filed with the SEC on October 14, 2014.

(b) Christian L. Oberbeck has sole voting and dispositive power with respect to 473,373 shares of Common Stock, shared voting and dispositive power with respect to 744,183 shares of Common Stock held by Elizabeth Oberbeck, shared voting and dispositive power with respect to 180,738 shares of Common Stock held by Saratoga Investment Advisors, LLC, an entity controlled by Mr. Oberbeck, and shared voting and dispositive power with respect to 174,035 shares of Common Stock held by CLO Partners LLC, an entity wholly owned by Mr. Oberbeck.

(c) Other than Mr. Oberbeck’s transfer of 744,183 shares of Common Stock to Elizabeth Oberbeck pursuant to the Transfer Agreement, there have been no transactions in the Issuer’s Common Stock effected by the Reporting Persons during the past 60 days.

(d) No person (other than the Reporting Persons and Elizabeth Oberbeck) is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares.

(e) Not applicable.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

Pursuant to the Transfer Agreement, Mr. Oberbeck transferred 744,183 shares of Common Stock beneficially owned by him (the “Transferred Shares”) to Ms. Oberbeck. Ms. Oberbeck has full ownership rights with respect to the Transferred Shares, including without limitation, the right to (A) receive any cash and/or stock dividends and distributions paid on or with respect to the shares and (B) sell the shares in accordance with the provisions of the Transfer Agreement and receive all proceeds therefrom. However, pursuant to the terms of the Transfer Agreement, Mr. Oberbeck has retained the right to vote the Transferred Shares, except that Ms. Oberbeck has retained the right to vote the Transferred Shares with respect to any corporate action that could give rise to dissenters or other rights of an objecting shareholder under Maryland General Corporation Law. The Transfer Agreement also contains a right of first refusal that requires Ms. Oberbeck to offer Mr. Oberbeck the opportunity to purchase the Transferred Shares and any other shares of Common Stock owned by her prior to her intended sale of the shares. In addition, Ms. Oberbeck has agreed to limit any sales of the Shares to one percent of the Issuer’s outstanding shares of Common Stock during any three month period until the second anniversary of the date of the Transfer Agreement.

Except as otherwise described in this Schedule 13D, there are no other contracts, arrangements, understandings or relationships (legal or otherwise) among the Reporting Persons and any other person with respect to any shares of Common Stock of the Company, including, but not limited to, transfer or voting of any of the Common Stock, finder’s fees, joint ventures, loan or option arrangements, put or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

Item 7 Materials to be Filed as Exhibits

Item 7 is hereby amended and restated in its entirety as follows:

 

Exhibit 1    Stock Purchase Agreement, dated as of April 14, 2010, GSC Investment Corp., Saratoga Investment Advisors, LLC and CLO Partners LLC (incorporated by reference to Exhibit 10.1 to the Issuer’s Current Report on Form 8-K filed June 4, 2010).


Exhibit 2    Registration Rights Agreement, dated as of July 30, 2010, by and between GSC Investment Corp., GSC CDO III L.L.C., Saratoga Investment Advisors, LLC, CLO Partners LLC and the other signatory parties thereto (incorporated by reference to Exhibit 10.4 to the Issuer’s Current Report on Form 8-K filed August 2, 2010).
Exhibit 3    Joint Filing Agreement, dated October 27, 2014
Exhibit 4    Agreement Relating to Shares of Common Stock of Saratoga Investment Corp., dated October 9, 2014


SIGNATURE

After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: October 27, 2014

 

CHRISTIAN L. OBERBECK
By:  

/s/ Christian L. Oberbeck

SARATOGA INVESTMENTS ADVISORS, LLC
By:  

/s/ Christian L. Oberbeck

  Name:  Christian L. Oberbeck
  Title: Managing Member
CLO PARTNERS LLC
By:  

/s/ Christian L. Oberbeck

  Name:  Christian L. Oberbeck
  Title: Managing Member
EX-3

EXHIBIT 3

AGREEMENT OF JOINT FILING

The undersigned acknowledge and agree that this Schedule 13D/A is filed on behalf of each of them and that all subsequent amendments to this Schedule 13D/A may be filed on behalf of each of them without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him, her or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he, she or it knows that such information is inaccurate.

Dated: October 27, 2014

 

CHRISTIAN L. OBERBECK
By:  

/s/ Christian L. Oberbeck

SARATOGA INVESTMENTS ADVISORS, LLC
By:  

/s/ Christian L. Oberbeck

  Name:  Christian L. Oberbeck
  Title: Managing Member
CLO PARTNERS LLC
By:  

/s/ Christian L. Oberbeck

  Name:  Christian L. Oberbeck
  Title: Managing Member
EX-4

Exhibit 4

AGREEMENT RELATING TO

SHARES OF COMMON STOCK OF

SARATOGA INVESTMENT CORP.

This AGREEMENT RELATING TO SHARES OF COMMON STOCK OF SARATOGA INVESTMENT CORP., dated as of October 9, 2014 (this “Agreement”), is entered into by and between Christian L. Oberbeck (and together with entities owned by, or affiliated with, him, the “Oberbeck Entities”) and Elizabeth Oberbeck (“Mrs. Oberbeck”).

RECITALS

WHEREAS, as of the date hereof, the Oberbeck Entities are the record and beneficial owners of 1,572,329 shares (the “CLO Shares”) of common stock, $0.001 par value per share (the “Common Stock”), of Saratoga Investment Corp. (the “Company”), as more fully set forth on Exhibit A;

WHEREAS, the Oberbeck Entities have agreed to transfer 744,183 shares (the “Transferred Shares”) of the CLO Shares to Mrs. Oberbeck, as more fully set forth on Exhibit A; and

WHEREAS, Mr. Oberbeck and Mrs. Oberbeck desire to enter into this Agreement to set forth their agreements and understandings with respect to the Transferred Shares and other matters relating thereto.

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and agreements contained herein, and intending to be legally bound hereby, the parties hereby agree as follows:

1. Transfer of the Transferred Shares.

(a) Mr. Oberbeck shall (i) within twenty four (24) hours of the effective time of the final decree of dissolution, deliver an irrevocable instruction and a legal opinion of counsel to the Company, each in the form attached hereto as Exhibit C-1 and Exhibit C-2, respectively, to American Stock Transfer & Trust Company, as the Company’s transfer agent (the “Transfer Agent”) and (ii) within three (3) business days of the effective time of the final decree of dissolution deliver, or cause to be delivered to the Transfer Agent, certificates representing the Transferred Shares to the extent such Transferred Shares are represented by physical certificates. Following the completion of the foregoing steps, the parties shall take such steps as may be reasonably required by the Transfer Agent to reflect the transfer (the “Transfer”) of record and beneficial ownership of the Transferred Shares to and in the name of Mrs. Oberbeck.

(b) Mrs. Oberbeck shall within twenty-four (24) hours of the effective time of the final decree of dissolution, deliver to the Company and counsel to the Company a representation letter in the form attached hereto as Exhibit D. Subject only to receipt by the Company and counsel to the Company of the Representation Letter, Mr. Oberbeck shall cause counsel to the Company to deliver to the Transfer Agent a legal opinion substantially in the form of Exhibit C-2 hereto and Mr. Oberbeck will cause the Company to cause the Transfer Agent


within three (3) business days of the effective time of the final decree of dissolution to remove all restrictive legends and stop orders on the Transferred Shares so as to enable the Transferred Shares to be freely saleable and tradable on the New York Stock Exchange or otherwise. The Oberbeck Entities will not take any action, and will not take any action to cause, the Company to place any stop order or other restrictions on the Transferred Shares.

(c) In the event that the Transferred Shares cannot be transferred with the restrictive legends removed in accordance with Section 1(b), the Oberbeck Entities shall (i) cause the Company to file (or update) a resale prospectus included within a Registration Statement on Form N-2 and take such steps to cause such registration statement to become effective as promptly as possible but in any event no later than eighty seven (87) days from the effective date of the final decree of dissolution and thereafter to keep such Registration Statement effective for so long as Mrs. Oberbeck owns any Transferred Shares or until the Transferred Shares may be sold without any limitation under Rule 144 and (ii) at the time of any sale of the Transferred Shares pursuant to such prospectus, cause the Transfer Agent to, or cause the Company to cause the Transfer Agent to, remove all restrictive legends and stop orders on the Transferred Shares so as to enable the Transferred Shares to be freely saleable and tradable on the New York Stock Exchange or otherwise.

(d) Notwithstanding the foregoing, the parties acknowledge and agree that the Transfer shall be deemed to have occurred as of the date of this Agreement and that Mrs. Oberbeck shall have all rights of ownership of the Transferred Shares on and after the date hereof, including without limitation, the right to any dividends declared thereon and payable to the record holder on or after the date hereof and the right to make any election to receive the manner of payment of such dividends, as more fully set forth in, and at all times subject to, Section 4, Section 6 and the other provisions of this Agreement. To the extent that, from and after the date of this Agreement, the Oberbeck Entities receive any payment or other distribution with respect to Transferred Shares, they shall hold them in trust for Mrs. Oberbeck and promptly (and in any event within two (2) business days thereof) pay or deliver such payment or other distribution to her; it being understood that the Oberbeck Entities are holding such amounts in trust, as a nominee, and that Mrs. Oberbeck shall be solely responsible for any taxes on such amounts.

2. Compliance with Laws. Mrs. Oberbeck agrees to comply with the federal securities laws in connection with her (i) receipt of the Transferred Shares, including, but not limited to, Sections 13 and 16 of the Securities Exchange Act of 1934 (the “Exchange Act”), and (ii) resale of the Transferred Shares. In order to facilitate Mrs. Oberbeck’s compliance with certain of these laws in connection with her receipt of the Transferred Shares, Mr. Oberbeck has agreed to file, or cause to be filed, the initial reports required by Sections 13 and 16 of the Exchange Act on behalf of Mrs. Oberbeck with the Securities and Exchange Commission. In addition, Mr. Oberbeck has agreed, if requested by Mrs. Oberbeck, to make arrangements to facilitate the timely filing of any subsequent reports required to be filed by Mrs. Oberbeck with the Securities and Exchange Commission pursuant to Sections 13 and 16 of the Exchange Act, but only so long as Mrs. Oberbeck agrees to reimburse Mr. Oberbeck for the legal and other out-of-pocket costs and expenses incurred by him in connection therewith not to exceed $1,000 in connection with each filing under Section 13 of the Exchange Act and $500 in connection with each filing under Section 16 of the Exchange Act.

 

2


3. Holding Period. Mrs. Oberbeck agrees that, during any given three month period during the Holding Period, she will not sell, offer to sell, transfer, hypothecate, contract to sell, grant any option to purchase, or otherwise dispose of (each, a “Disposition” and collectively, the “Dispositions”) any Transferred Shares and/or DRIP Shares (as defined below and together with the Transferred Shares, the “Shares”) in the aggregate in an amount, when combined with the Shares sold by any Permitted Transferee or Subsequent Holder (as each such term is defined herein) during such period, in excess of one percent (1%) of the Company’s outstanding shares of Common Stock. After the Holding Period, she will only Dispose of the Shares in accordance with the provisions of this Agreement and applicable law. The “Holding Period” shall be the period beginning on the date of this Agreement and ending on the second anniversary of the date of this Agreement. Any and all Dispositions of Shares by Mrs. Oberbeck will be in accordance with the Securities Act of 1933 (the “Securities Act”).

4. Rights as Shareholder. Mrs. Oberbeck agrees that, except for the grant of the proxy referred to below in this Section 4 and the provisions regarding transfer set forth in this Agreement, from and after the date of this Agreement, she will have full ownership rights with respect to the Transferred Shares, including without limitation, the right to (A) receive any cash and/or stock dividends and distributions paid on or with respect to the Shares, (B) sell the Shares in accordance with the provisions of this Agreement and the Securities Act, and receive all proceeds therefrom, (C) participate or not participate in the Company’s dividend reinvestment plan (the “DRIP”); (D) make applicable elections in connection with any stock/cash dividend or distribution with respect to the Shares (the “Cash/Stock Dividend”), and (E) receive any consideration paid for or on the Shares in connection with any merger or other similar transaction involving the Company, and to the extent any such amounts are paid or ownership rights are delivered to the Oberbeck Entities, he shall hold them in trust for Mrs. Oberbeck and promptly (and in any event within two (2) business days thereof) pay or deliver them over to her. Any shares of Common Stock received by Mrs. Oberbeck in connection with the DRIP or any Cash/Stock Dividend are referred to herein as the “DRIP Shares.” Notwithstanding the foregoing, Mrs. Oberbeck agrees that, except with respect to any corporate action that could give rise to dissenters or other rights of an objecting shareholder under Title 3, Subtitle 2 of the Maryland General Corporation Law, the right to vote any Transferred Shares will be held by Mr. Oberbeck for so long as Mrs. Oberbeck or any Permitted Transferee (as defined herein) or any other subsequent holder of Transferred Shares which received the Transferred Shares from Mrs. Oberbeck in a Non-Arm’s-Length Transaction (such a subsequent holder is referred to herein as a “Subsequent Holder”) and, accordingly, Mrs. Oberbeck agrees to execute an irrevocable proxy in favor of Mr. Oberbeck with respect to the Transferred Shares in the form attached hereto as Exhibit B and take any other action that may be reasonably requested Mr. Oberbeck to ensure that he retains the voting rights granted to him in this Agreement with respect to any Transferred Shares held by a Permitted Transferee or a Subsequent Holder. For avoidance of doubt; it is the intention of the parties that Mrs. Oberbeck shall retain her voting rights in connection with any corporate action that could give rise to dissenters or other rights of an objecting shareholder under Title 3, Subtitle 2 of the Maryland General Corporation Law such that Mrs. Oberbeck will maintain the ability to exercise such dissenters or other rights of an objecting shareholder. For purposes hereof, the term “Non-Arm’s-Length Transaction” means a transaction that is not characterized by a selling price and other terms and conditions that would prevail in a typical sale transaction between two unrelated parties.

 

3


5. Dispositions.

(a) Any Dispositions of the Shares by Mrs. Oberbeck, including on the New York Stock Exchange or any other securities exchange on which the Shares are then traded (a “Public Sale”), or pursuant to a private Disposition (a “Private Sale”), will be made pursuant the terms set forth below in Section 6.

(b) Following the end of the Holding Period, Mrs. Oberbeck shall be permitted to effectuate Public Sales and Private Sales of the Shares without any limitation other than any requirements imposed by the Securities Act or Section 6 below.

6. Rights of First Refusal.

(a) Right of First Refusal for Dispositions Pursuant to a Public Sale.

(i) Grant. For so long as Mrs. Oberbeck owns any Shares, Mrs. Oberbeck unconditionally and irrevocably grants to Mr. Oberbeck the right to purchase some or all of the Shares that Mrs. Oberbeck is permitted to sell pursuant to a Public Sale upon the terms and conditions of this Section 6(a).

(ii) Offer Notices. The procedures set forth in this Section 6(a)(ii), including the purchase right described herein, shall apply each time that the Shares are to be sold pursuant to a Public Sale. Specifically, Mrs. Oberbeck will instruct her broker (the “Broker”) who is administering the Public Sale to offer Mr. Oberbeck (the “Public Sale Offer”), by notice given to Mr. Oberbeck’s email address set forth in Section 10(d)(1), the opportunity to purchase all (or, at Mr. Oberbeck’s election, less than all) of the Shares to be sold pursuant to a Public Sale on the immediately succeeding Trading Day, which Public Sale Offer shall be made by no later than 8:00 p.m. New York City time on the day immediately prior to the Trading Day on which the Broker intends to execute a sale of the Shares (the “Public Sale Trading Day”). The Public Sale Offer shall specify (w) the maximum number of Shares which the Broker may sell on such Trading Day, (x) the Last Closing Price (as defined below), (y) the email address to be used for acceptance of the Public Sale Offer, and (z) the wire transfer instructions for payment if Mr. Oberbeck elects to purchase any Shares.

(iii) Acceptance Notices. If Mr. Oberbeck desires to accept the offer to purchase some or all of the Shares, he shall deliver a notice (a “Public Sale Acceptance”) by email to the Broker at the email address set forth in the Public Sale Offer at any time prior 8:30 a.m. New York City time on the applicable Public Sale Trading Day, which Public Sale Acceptance shall specify the number of shares that he desires to purchase (which number shall not exceed the maximum number of shares set forth in the Public Sale Offer), which offer and acceptance shall be binding on the parties.

(iv) Rejected Offer. If Mr. Oberbeck does not deliver a Public Sale Acceptance prior to 8:30 am on the applicable Public Sale Trading Day or otherwise declines to accept a Public Sale Offer (a “Rejected Offer”), then the Broker may execute the sale of the applicable Shares on the New York Stock Exchange (or any other securities exchange on which the Shares are then traded) on the applicable Public Sale Trading Day thereof, it being understood that nothing shall obligate Mrs. Oberbeck to sell any Shares pursuant to a Public Sale

 

4


Offer that are not subject to a Public Sale Acceptance. If the Broker does not execute the sale of all of the applicable Shares on the applicable Public Sale Trading Day, the Broker must then reoffer Mr. Oberbeck the opportunity, in accordance with the terms of this Section 6, to purchase the applicable Shares in the manner set forth above each time Mrs. Oberbeck determines to sell Shares in a Public Sale.

(v) Purchase Price and Payment.

(1) The purchase price per share for the applicable Shares to be sold to Mr. Oberbeck pursuant to a Public Sale Acceptance (that has not been withdrawn) will equal the Closing Price on the Trading Day on which the Public Sale Offer is received by Mr. Oberbeck (the “Last Closing Price”) and the settlement of the sale will occur within three trading days after the applicable Public Sale Trading Day.

(2) Mr. Oberbeck shall pay Mrs. Oberbeck for any Shares purchased by him pursuant to the right granted under Section 6(a) within three (3) Trading Days after the date of the applicable Public Sale Trading Day by wire transfer of immediately available funds, against delivery of the Shares to Mr. Oberbeck.

(b) Right of First Refusal for Dispositions Pursuant to a Private Sale.

(i) Grant. For so long as Mrs. Oberbeck owns any Shares, Mrs. Oberbeck unconditionally and irrevocably grants to Mr. Oberbeck the right to purchase some or all of the Shares that Mrs. Oberbeck is permitted to sell pursuant to a Private Sale upon the terms and conditions of this Section 6(b).

(ii) Offer Notices. The procedures set forth in this Section 6(b)(ii), including the purchase right described herein, shall apply each time that the Shares are to be sold pursuant to a Private Sale. Specifically, in the event that Mrs. Oberbeck has received a bona fide third-party offer to purchase, or has otherwise agreed to sell, any of her Shares in a Private Sale (including in each case pursuant to a Non-Arm’s-Length Transaction), and Mrs. Oberbeck has determined to accept such offer or enter into such sale transaction, Mrs. Oberbeck will, or will instruct the Broker who is administering the Private Sale to, offer Mr. Oberbeck (the “Private Sale Offer”), by notice given to Mr. Oberbeck’s email address set forth in Section 10(d)(i), the opportunity to purchase all (or, at Mr. Oberbeck’s election, less than all) of the Shares to be sold pursuant to a Private Sale on the immediately succeeding Trading Day, which Private Sale Offer shall be made by no later than 8:00 p.m. New York City time on the day immediately prior to the Trading Day on which the Private Sale is scheduled to close (the “Private Sale Trading Day”). The Private Sale Offer shall (v) specify the number of Shares proposed to be sold in the Private Sale, (w) specify the purchase price per Share (the “Definitive Per Share Purchase Price”), (x) specify the email address to be used for acceptance of the Private Sale Offer, (y) include a copy of the definitive written agreement to purchase the Shares, and (z) provide wire transfer instructions for payment if Mr. Oberbeck elects to purchase any Shares.

(iii) Acceptance Notices. If Mr. Oberbeck desires to accept the offer to purchase some or all of the Shares, he shall deliver a notice (a “Private Sale Acceptance”) by email to the Broker at the email address set forth in the Private Sale Offer at any time prior 8:30 a.m.

 

5


New York City time on the applicable Private Sale Trading Day, which Private Sale Acceptance shall specify the number of Shares that he desires to purchase (which number shall not exceed the maximum number of Shares set forth in the Private Sale Offer), which offer and acceptance shall be binding on the parties.

(iv) Rejected Offer. If Mr. Oberbeck does not deliver a Private Sale Acceptance prior to 8:30 am on the applicable Private Sale Trading Day or otherwise declines to accept a Private Sale Offer (a “Rejected Offer”), then the Broker may execute the sale of the applicable Private Sale on the applicable Private Sale Trading Day upon the terms set forth in the Private Sale Offer notice, it being understood that nothing shall obligate Mrs. Oberbeck to sell any Shares pursuant to a Private Sale Offer that are not subject to a Private Sale Acceptance. If the Broker does not execute the sale of all of the applicable offered Shares on the applicable Private Sale Trading Day, the Broker must then reoffer Mr. Oberbeck the opportunity to purchase the applicable Shares in the manner set forth above immediately prior to each time that Mrs. Oberbeck determines to sell Shares in a Private Sale in accordance with the terms of this Section 6.

(v) Purchase Price and Payment.

(1) The purchase price per share for the applicable Shares to be sold to Mr. Oberbeck pursuant to Private Sale Acceptance (that has not been withdrawn) will equal the Definitive Per Share Purchase Price and the settlement of the sale will occur within three trading days after the applicable Private Sale Trading Day.

(2) Mr. Oberbeck shall pay Mrs. Oberbeck for any Shares purchased by him pursuant to the right granted under Section 6(a) within three (3) Trading Days after the date of the applicable Private Sale Trading Day by wire transfer of immediately available funds, against delivery of the Shares to Mr. Oberbeck.

(c) Failure to Pay. In the event Mr. Oberbeck delivers a Public Sale Acceptance or Private Sale Acceptance in accordance with Section 6(a)(iii) or 6(b)(iii), as applicable, but fails to make payment for some or all of the relevant Shares within the time frames set forth in Section 6(a)(v) or 6(b)(v), Mrs. Oberbeck may, on the Trading Day immediately following the Trading Day on which payment was due in accordance with Section 6(a)(v) or 6(b)(v), sell in a Public Sale any of the subject Shares that were not acquired by Mr. Oberbeck and, in the event Mrs. Oberbeck incurs damages as a result of such Public Sale, Mr. Oberbeck shall be liable to Mrs. Oberbeck for the full amount of such damages

(d) Notice After Holding Period. Notwithstanding anything to the contrary contained in the foregoing Section 6(a)(ii) and 6(b)(ii), in the event Mrs. Oberbeck desires to sell Shares pursuant to a Public Sale or Private Sale following the end of the Holding Period, Mrs. Oberbeck shall give notice to Mr. Oberbeck as follows: (i) if the proposed Public Sale or Private Sale involves the sale of less than or equal to 1% of the issued and outstanding Common Stock, notice must be received by Mr. Oberbeck no later than 8:00 p.m. on the Trading Day immediately preceding the Public Sale Trading Day or Private Sale Trading Day, as applicable; and (ii) if the proposed Public Sale or Private Sale involves the sale of greater than 1% of the issued and outstanding Common Stock, notice must be received by Mr. Oberbeck no later than 8:00 p.m. on the third (3rd) Trading Day immediately preceding the Public Sale Trading Day or Private Sale Trading Day, as applicable.

 

6


(e) Right to Assign. Any such purchases pursuant to this Section 6 may be made either directly by Mr. Oberbeck or through any entities affiliated with him.

(f) Application of Rights of First Refusal to Permitted Transferees and Subsequent Holders. The rights granted by Mrs. Oberbeck to Mr. Oberbeck pursuant to this Section 6 shall apply to any Shares held by a Permitted Transferee or a Subsequent Holder and Mrs. Oberbeck agrees that she will not Dispose of the Shares to a Permitted Transferee or a Subsequent Holder without first obtaining their written agreement to comply with this Section 6 and the other provisions of this Agreement and otherwise agrees to take any action that may be reasonably requested Mr. Oberbeck to ensure that a Permitted Transferee or a Subsequent Holder abides by the terms hereof in connection with any Disposition of Shares.

7. Insider Status. Mrs. Oberbeck acknowledges and understands that Mr. Oberbeck is an executive officer and director of the Company and, as a result, may from time to time possess material nonpublic information not known to Mrs. Oberbeck that may impact the value of the Shares, and that Mr. Oberbeck may be unable to disclose to Mrs. Oberbeck. Mrs. Oberbeck understands the disadvantage to which she is subject due to the disparity of information between her and Mr. Oberbeck. Notwithstanding this fact, Mrs. Oberbeck has deemed it appropriate to enter into this Agreement and to engage in any of the purchases transactions contemplated in Section 6 of this Agreement with Mr. Oberbeck. From and after the date of this Agreement, the Oberbeck Entities agree not to (i) provide Mrs. Oberbeck any material nonpublic information concerning the Company unless required by law or legal process, or (ii) seek to prevent Mrs. Oberbeck from completing a sale of Transferred Shares based on a claim by the Oberbeck Entities that Mrs. Oberbeck possesses material nonpublic information or is an affiliate or both or otherwise initiate or commence directly or through another other person or entity, any claim or action against Mrs. Oberbeck on the grounds that she possesses material nonpublic information or is an affiliate or both.

8. Permitted Transfers. Notwithstanding anything else to the contrary set forth in this Agreement, Mrs. Oberbeck may Dispose of any of the Shares to any of the following (each a “Permitted Transferee”): (a) descendants (excluding adoptive relationships and stepchildren) and the spouses of such descendants (collectively, “Family Members”); (b) a trust under which the distribution of Shares may be made only to Mrs. Oberbeck and/or her Family Members; (c) a charitable remainder trust, the income from which will be paid only to Mrs. Oberbeck during her life; (d) a corporation, partnership or limited liability company, the stockholders, partners or members of which are only Mrs. Oberbeck and/or her Family Members; or (e) for bona fide estate planning purposes, either by will or by the laws of intestate succession, to Mrs. Oberbeck’s executors, administrators, testamentary trustees, legatees or beneficiaries; provided, that each such transferee described in clauses (a) through (e) above agrees in writing to be bound by the terms of this Agreement; provided, further, that any corporation, partnership or limited liability company described in clause (d) above and Mrs. Oberbeck and/or her Family Members that are the equity owners thereof each agree in writing to not transfer or otherwise Dispose of any equity or other interests in such corporation, partnership and limited liability company for so long as such corporation, partnership or limited liability company holds Shares.

 

7


9. Representations and Warranties.

(a) Mr. Oberbeck represents and warrants to Mrs. Oberbeck that as of the date hereof and as of the date record ownership is transferred to Mrs. Oberbeck, (i) he and entities owned by, or affiliated with, him hold (and will hold) good and valid title to the Transferred Shares owned by him or such entities, and there are no (and will not be any) liens, claims or encumbrances against the Transferred Shares nor have any of the Transferred Shares been (or will be) pledged as security for any obligation, (ii) this Agreement constitutes a valid and binding obligation of Mr. Oberbeck, enforceable against him in accordance with its terms, (iii) the execution and delivery of this Agreement does not (A) conflict with any document, agreement or instrument to which any of the Oberbeck Entities are a party, or (B) require that any of the Oberbeck Entities obtain any consent or approval of, or that he give notice to, any person and (iv) the ownership and other information set forth on Exhibit A is true, complete and correct and except as set forth on Exhibit A. none of the Oberbeck Entities nor any of Mr. Oberbeck’s affiliates own beneficially or of record any shares of capital stock of the Company or have any rights to acquire any shares.

(b) Mrs. Oberbeck represents and warrants to Mr. Oberbeck that (i) this Agreement constitutes a valid and binding obligation of Mrs. Oberbeck, enforceable against her in accordance with its terms, and (ii) the execution and delivery of this Agreement does not (A) conflict with any document, agreement or instrument to which Mrs. Oberbeck is a party, or (B) require that Mrs. Oberbeck obtain any consent or approval of, or that she give notice to, any person.

(c) Mrs. Oberbeck (i) further represents and warrants to Mr. Oberbeck that neither she nor any of her representatives or agents has had any communication with any five percent (5%) or greater holder of shares of the Common Stock and (ii) agrees to provide Mr. Oberbeck with prompt notice if any such communications occur after the date of this Agreement and until such time that she no longer owns any Shares as well as a detailed description of the substance thereof and otherwise promptly respond to questions posed by Mr. Oberbeck relating thereto.

10. Miscellaneous.

(a) Effectiveness and Entire Agreement. Notwithstanding anything to the contrary contained herein, this Agreement shall only become effective upon the effectiveness of the final decree of dissolution. In addition, this Agreement (including the irrevocable proxy referred to herein) constitutes the entire agreement and supersedes all other prior agreements and understandings, both written and oral, among the parties, or any of them, with respect to the subject matter hereof.

(b) Successors and Assigns. This Agreement shall not be assigned by operation of law or otherwise without the prior written consent of the other party hereto. This Agreement shall be binding upon, inure to the benefit of and be enforceable by each party and such party’s respective heirs, beneficiaries, executors, representatives and permitted assigns.

 

8


(c) Amendment and Modification. This Agreement may not be amended, altered, supplemented or otherwise modified or terminated except upon the execution and delivery of a written agreement executed by the parties hereto.

(d) Notices. All notices and other communications hereunder shall be in writing and shall be deemed given (i) when delivered, if delivered by hand, (ii) one (1) trading day after transmitted, if transmitted by a nationally recognized overnight courier service (providing written proof of delivery), (iii) on the date sent by e-mail (with confirmation of receipt) if sent during normal business hours of the recipient, and on the next trading day if sent after normal business hours of the recipient, or (d) three (3) trading days after mailing, if mailed by registered or certified mail (return receipt requested), to the parties at the following addresses or email addresses (or at such other address or email address for a party as shall be specified by like notice):

 

  (i) if to Mr. Oberbeck, to:
     535 Madison Avenue
     New York, New York, 10022

 

     Telephone No.: (646) 515-6748
     Email address:
     coberbeck@saratogapartners.com

 

  (ii) if to Mrs. Oberbeck, to:
     630 Lake Avenue
     Greenwich, CT 06830

 

     Telephone No. 203 249 3202
     Email address:
     elizabethoberbeck@gmail.com

(e) Severability. In the event that any provision of this Agreement or the application thereof, becomes or is declared by a court of competent jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect and the application of such provision to other persons or circumstances will be interpreted so as reasonably to effect the intent of the parties hereto. The parties further agree to replace such void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent possible, the economic, financial and other purposes of such void or unenforceable provision.

(f) Other Remedies; Specific Performance. Except as otherwise provided herein, any and all remedies herein expressly conferred upon a party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such party, and the exercise by a party of any one remedy will not preclude the exercise of any other remedy. The parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled to seek an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in any court of the United States or any state having jurisdiction, this being in addition to any other remedy to which they are entitled at law or in equity.

 

9


(g) No Waiver; Remedies Cumulative. No failure or delay on the part of any party hereto in the exercise of any right hereunder will impair such right or be construed to be a waiver of, or acquiescence in, any breach of any representation, warranty or agreement herein, nor will any single or partial exercise of any such right preclude other or further exercise thereof or of any other right. Except as otherwise provided herein, all rights and remedies existing under this Agreement are cumulative to, and not exclusive to, and not exclusive of, any rights or remedies otherwise available and the exercise by a party of any one remedy will not preclude the exercise of any other remedy.

(h) Definition of Trading Day and Closing Price. As used in this Agreement, (i) the term “Trading Day” means a day on which the principal national securities exchange on which the Common Stock is listed is open for business, and (ii) “Closing Price” means, with respect to a given Trading Day, the last price at which the Common Stock traded during a regular trading session on such Trading Day on such principal national securities exchange.

(i) Governing Law. This Agreement shall be governed and construed in accordance with the laws of the State of New York, without giving effect to the principles of conflict of law thereof.

(j) Counterparts. This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same agreement and shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other party, it being understood that all parties need not sign the same counterpart.

IN WITNESS WHEREOF, Mr. Oberbeck and Mrs. Oberbeck have caused this Agreement to be duly executed as of the day and year first written above.

 

/s/ Christian L. Oberbeck

Christian L. Oberbeck

/s/ Elizabeth Oberbeck

Elizabeth Oberbeck

 

10